Clinical Trial

CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation

Recruiting
View on ClinicalTrials.gov →
Summary
This feasibility study will be conducted to demonstrate the initial safety and effectiveness of the CellFX® nsPFA™ Cardiac Clamp in performing a box lesion around the 4 pulmonary veins as an isolated procedure or as a part of a more extensive surgical ablation set in conjunction with concomitant cardiac surgical procedure.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-04-06; most recent amendment 2026-01-09.
Status change: Not Yet Recruiting → Recruiting 2024-07-26
Trial Details
NCT Number NCT06355063
Lead Sponsor Pulse Biosciences, Inc.
Collaborators: Avania
Conditions Atrial Fibrillation, Surgery, Ablation of Atrial Fibrillation, Clamp Study
Enrollment 30 participants
Start Date 2024-07-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-12